COMMUNIQUÉS West-GlobeNewswire

Radient Technologies Inc. Announces Shares for Services Issuance
24/01/2018
EDMONTON, Alberta, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Corporation”) (TSX Venture:RTI) announces that the Corporation has issued an aggregate of 28,024 common shares to third [...]
HealthEquity to Announce Year-End HSAs and Custodial Assets
24/01/2018
DRAPER, Utah, Jan. 23, 2018 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY ) (“HealthEquity” or the “Company”), the nation’s largest health savings account (“HSA”) non-bank custodian, today announced that it plans [...]
National Research Corporation Chief Executive Officer Continues Estate Plan
24/01/2018
Lincoln, Nebraska, Jan. 23, 2018 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ: NRCIA and NRCIB) today announced that over the next few weeks, CEO Michael D. Hays will be gifting and/or transferring his [...]
Sanofi: Availability of the Pre-quarterly Results Communication
23/01/2018
Availability of the Pre-quarterly Results Communication Paris, France - January 23, 2018 - Sanofi announced today that its Pre-Quarterly Results Communication document is available on the "Investors" page of the company [...]
Sanofi : Mise en ligne du document «Pre-quarterly Results Communication »
23/01/2018
Mise en ligne du document «Pre-quarterly Results Communication » Paris, France - Le 23 janvier 2018 - Sanofi annonce la mise en ligne sur l'espace Investisseurs du site internet de la société, d'un document intitulé « [...]
Cocrystal Pharma Provides Update on Reverse Stock Split
23/01/2018
- Reverse stock split to be effective on Wednesday, January 24, 2018 on split-adjusted basis under trading symbol “COCPD” - ATLANTA, GA and BOTHELL, WA, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (OTCQB: [...]
MacroGenics Announces Continuation of SOPHIA Study of Margetuximab Based on Completion of Interim Futility Analysis
23/01/2018
Rockville, MD, Jan. 23, 2018 (GLOBE NEWSWIRE) -- -- MacroGenics, Inc. (NASDAQ: MGNX ), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics [...]
Strongbridge Biopharma plc Announces Proposed Public Offering of 5 Million Ordinary Shares
23/01/2018
DUBLIN, Ireland and TREVOSE, Pa., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP ) (the “Company”) today announced that it intends to offer and sell 5 million of its ordinary shares in an [...]
UroGen Pharma Announces Closing of Upsized Public Offering of Ordinary Shares and Full Exercise of Underwriters' Option
23/01/2018
RA’ANANA, Israel and NEW YORK, Jan. 23, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN ), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with [...]
Agios Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
23/01/2018
CAMBRIDGE, Mass., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO ) today announced the closing of its previously announced underwritten public offering of common stock, including the [...]
HTG Molecular Diagnostics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
23/01/2018
TUCSON, Ariz., Jan. 23, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM ) (HTG), a provider of instruments, reagents and services for molecular profiling applications, today announced the [...]
Five Prime Announces Proposed Public Offering of Common Stock
23/01/2018
SOUTH SAN FRANCISCO, Calif., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq: FPRX ), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology [...]
Leading Medical Organizations Update Guideline for Molecular Testing and Targeted Therapies in Lung Cancer
23/01/2018
DENVER, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Rapid advancements in the molecular diagnostic testing of lung cancer have led to new treatments and greater hope for patients battling lung cancer, the most common cause of [...]
Trident Brands Appoints Senior Industry Executive Bob Dufour To Advisory Board
23/01/2018
BROOKFIELD, WI, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Trident Brands, Inc. (OTCQB: TDNT), a consumer products company focused on novel and unique branded products, private label manufacturing and proprietary innovation [...]
United American Healthcare Corporation Reports Strong Income Growth in Q3 Fiscal Year 2017 Propelled by Performance of its Wholly Owned Subsidiaries
23/01/2018
CHICAGO, Jan. 23, 2018 (GLOBE NEWSWIRE) -- United American Healthcare Corporation (OTC:UAHC) (the “Company” or “UAHC Parent”), today announced the release of its unaudited third quarter report ending September 30, 2017 [...]
Barbara Ann Karmanos Cancer Institute receives 2018 Women’s Choice Award® as one of America’s Best Hospitals for Cancer Care & Research
23/01/2018
DETROIT, Jan. 23, 2018 (GLOBE NEWSWIRE) -- The Barbara Ann Karmanos Cancer Institute has been named one of America’s Best Hospitals for Cancer Care & Research by the Women’s Choice Award ® for 2018. Previously, [...]
Nohla Therapeutics Granted Orphan Drug Designation in the European Union for NLA101 in the Treatment of Hematopoietic Stem Cell Transplantation
23/01/2018
SEATTLE, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a clinical stage biopharmaceutical company focused on the development of universal donor, off-the-shelf cell therapies to treat cancer and [...]
Premier Biomedical Launches Hemp Oil Based Topical Pain Relief Ointment
23/01/2018
JACKSON CENTER, Pa., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTC:BIEI) announced introduction of a new hemp oil based topical ointment to complement its existing topical pain relief products, which [...]
Cynata Executes MoU for Commercial Evaluation with Celularity, Inc.
23/01/2018
MoU signed with Celularity, Inc. for the evaluation of and identification of commercial opportunities for the Cymerus TM platform and Celularity’s leading cell therapy assets Follows encouraging early clinical data in [...]

Pages